Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates

[1]  S. Ram,et al.  Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera , 2008, Infection and Immunity.

[2]  D. Uhrín,et al.  A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H1 , 2008, The Journal of Immunology.

[3]  P. Zipfel,et al.  Factor H family proteins and human diseases. , 2008, Trends in immunology.

[4]  A. van der Ende,et al.  Clinical Features, Outcome, and Meningococcal Genotype in 258 Adults With Meningococcal Meningitis: A Prospective Cohort Study , 2008, Medicine.

[5]  D. Granoff,et al.  Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines , 2008, Infection and Immunity.

[6]  John D. Lambris,et al.  Complement evasion by human pathogens , 2008, Nature Reviews Microbiology.

[7]  D. Uhrín,et al.  Structural basis for complement factor H–linked age-related macular degeneration , 2007, The Journal of experimental medicine.

[8]  B. Greenwood,et al.  Epidemic meningitis, meningococcaemia, and Neisseria meningitidis , 2007, The Lancet.

[9]  P. Roversi,et al.  Expression, purification, cocrystallization and preliminary crystallographic analysis of sucrose octasulfate/human complement regulator factor H SCRs 6-8. , 2007, Acta crystallographica. Section F, Structural biology and crystallization communications.

[10]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[11]  David N. Messina,et al.  Evolutionary and Biomedical Insights from the Rhesus Macaque Genome , 2007, Science.

[12]  G N Murshudov,et al.  SPINE workshop on automated X-ray analysis: a progress report. , 2006, Acta crystallographica. Section D, Biological crystallography.

[13]  Malcolm Guiver,et al.  Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. , 2006, Journal of medical microbiology.

[14]  David H Perlman,et al.  The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance , 2006, The Journal of Immunology.

[15]  Robert B Sim,et al.  Functional Significance of Factor H Binding to Neisseria meningitidis1 , 2006, The Journal of Immunology.

[16]  R. Rappuoli,et al.  Solution Structure of the Immunodominant Domain of Protective Antigen GNA1870 of Neisseria meningitidis* , 2006, Journal of Biological Chemistry.

[17]  L. Harrison.  Prospects for Vaccine Prevention of Meningococcal Infection , 2006, Clinical Microbiology Reviews.

[18]  M. Hibberd,et al.  Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients , 2006, Scandinavian journal of infectious diseases.

[19]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[21]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[22]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[23]  R. Rappuoli,et al.  The Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies , 2005, Infection and Immunity.

[24]  G. Bricogne,et al.  Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. , 2004, Acta crystallographica. Section D, Biological crystallography.

[25]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[26]  A. Peschel,et al.  Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson. , 2004, International journal of medical microbiology : IJMM.

[27]  Ying Zhang,et al.  Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein , 2004, Infection and Immunity.

[28]  Jeannette Adu-Bobie,et al.  Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870 , 2003, The Journal of experimental medicine.

[29]  A. Vagin,et al.  Spherically averaged phased translation function and its application to the search for molecules and fragments in electron-density maps. , 2001, Acta crystallographica. Section D, Biological crystallography.

[30]  S. Meri,et al.  The factor H protein family. , 1999, Immunopharmacology.

[31]  K Cowtan,et al.  Miscellaneous algorithms for density modification. , 1998, Acta crystallographica. Section D, Biological crystallography.

[32]  S. Meri,et al.  Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti‐factor H antibodies: evidence for multiple interactions between H and surface bound C3b , 1996, FEBS letters.

[33]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[34]  S. Meri,et al.  Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Padlan,et al.  Antibody-antigen complexes. , 1988, Annual review of biochemistry.

[36]  M. Palmer,et al.  Monoclonal antibodies against the complement control protein Factor H (β1 H) , 1983 .

[37]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[38]  Rui Zhang,et al.  Data Reduction , 2009, Encyclopedia of Database Systems.

[39]  M D Winn,et al.  An overview of the CCP4 project in protein crystallography: an example of a collaborative project. , 2003, Journal of synchrotron radiation.

[40]  G. Bricogne,et al.  [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. , 1997, Methods in enzymology.

[41]  U Rother,et al.  Biological functions of the complement system. , 1986, Progress in allergy.

[42]  M. Palmer,et al.  Monoclonal antibodies against the complement control protein factor H (beta 1 H). , 1983, Bioscience reports.

[43]  W. Rossiter,et al.  Progress report , 1954, Research newsletter. College of General Practitioners.